INVO Fertility (IVF) Net Margin (2011 - 2026)
INVO Fertility's (IVF) quarterly Net Margin came in at 86.73% in Q1 2026, up 88514.0% year-on-year from N/an in Q1 2025, and up 42.38% on a QoQ basis from 150.51% in Q3 2025.
INVO Fertility (IVF) Net Margin (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of Net Margin data on file, last reported at 86.73% in Q1 2026.
- On a quarterly basis, Net Margin rose 88514.0% year-over-year to 86.73% in Q1 2026; TTM through Mar 2026 was 125.61%, a 23328.0% increase from a year earlier, with the FY2024 full-year figure at 143.09%, up 12291.0% from the prior year.
- Net Margin for Q1 2026 stood at 86.73%, up from 150.51% in the prior quarter.
- Over the last five years, Net Margin for IVF reached as high as 86.73% in Q1 2026 and fell as low as 1917.09% in Q2 2022.
- Historically, Net Margin has averaged 598.81% across 5 years, with a median of 256.68% in 2025.
- Across the five-year window, Net Margin tumbled 145505 bps in 2022 and surged 120785 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 994.72% in 2022, then soared by 86 bps to 142.21% in 2023, then tumbled by 62 bps to 229.79% in 2024, then soared by 34 bps to 150.51% in 2025, then soared by 42 bps to 86.73% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 86.73% in Q1 2026, 150.51% in Q3 2025, and 283.58% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -86.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.73% |
| Sep 30, 2025 | -150.51% |
| Jun 30, 2025 | -283.58% |
| Mar 31, 2025 | -971.87% |
| Dec 31, 2024 | -229.79% |
| Sep 30, 2024 | -113.78% |
| Jun 30, 2024 | -122.25% |
| Mar 31, 2024 | -101.28% |
| Dec 31, 2023 | -142.21% |
| Sep 30, 2023 | -128.06% |
| Jun 30, 2023 | -709.24% |
| Mar 31, 2023 | -732.96% |
| Dec 31, 2022 | -994.72% |
| Sep 30, 2022 | -1,083.47% |
| Jun 30, 2022 | -1,917.09% |
| Mar 31, 2022 | -1,813.47% |
| Dec 31, 2021 | 3.34% |
| Sep 30, 2021 | -1,024.69% |
| Jun 30, 2021 | -871.66% |
| Mar 31, 2021 | -358.42% |